Products Category
Antibody-drug Conjugate/ADC Related
Ksp
Contact Us
Tel: 0519-85788828
Fax: 0519-89960117
Mobile: 13775037613
E-mail: sales@chemrenpharm.com
Add: 169 Qingliang Road, Changzhou, Jiangsu,China
QQ:
2500035664
|
| Details: |
Description of:TAK-901
After binding of TAK-901 to Aurora B, it inhibits the activity of Aurora B, which may result in a reduction in the proliferation of tumor cells that overexpress Aurora B. TAK-901 is originally developed by Millennium Pharmaceuticals, Inc.. Theoretical analysis:TAK-901 M.Wt: 504.64 Formula: C28H32N4O3S Solubility: Unknown Purity: >98% Storage: at -20℃ 2 years CAS No: 934541-31-8 Availability and price: Pakage：200mg/500mg/1g/2g We offer significant discount for larger quantity order. For quotation, question, and order, please send email to : sales@chemrenpharm.com Quality control data: Quality Control by H-NMR,C-NMR,LC-MS,HPLC. Product will be shipped with supporting analytical data. Fast delivery about 4-5 working days |
| Related Products : |
Chinese
Deutsch
Espanol
Francais
Italiano
Portugues
Japanese
Korean
Arabic
Russian